In this article, we will be taking a look at the 9 Most Undervalued Pharma Stocks to Buy Right Now. The U.S. pharmaceutical industry in 2025 remains one of the nation’s most dynamic and profitable ...
In this article, we will look at the 10 Best Performing Pharma Stocks in 2025. On January 8, Michael Yee, global head of biotech research at UBS, appeared on CNBC’s ‘Squawk on the Street’ to discuss ...
India, Jan. 24 -- With cancer incidence rising globally, several Indian pharmaceutical companies are strengthening their ...
Not all growth opportunities require aggressive risk-taking. Investors seeking to build a strong portfolio with steady income and long-term wealth creation can benefit from adding dividend-paying ...
Today's pharmaceutical stocks are facing the challenges of government-imposed drug price caps, waning demand for COVID-19 vaccines and global stock market upheaval. However, the industry's major ...
Sudarshan Pharma shares surged nearly 4% to ₹20.25 after reporting Q3FY26 revenue of ₹158.37 crore, a 37% YoY increase. Net profit rose 56% to ₹43.05 crore. Despite a 27.40% drop in January, the stock ...